Location: Home
  • search
  • go
  • Relate News
  • 11/18/2025XLifeSc and RNAimmune Enter Strategic Collaboration
  • 11/18/2025Qilu to Share First-in-Human Data of Trispecific Antibody QLS4131 at A...
  • 11/18/2025China Bets on Hong Kong's CMPR to Become a Global Regulatory Power
  • 11/18/2025Bayer Opens Beijing E-Town Biopharma Incubator, Naming First Residents
  • 11/18/2025Chinese Biopharma Firms Flock to Hong Kong IPOs as Investor Demand Rem...
  • 11/18/2025India and China Explore Reverse-Trade Model for Pharmaceuticals
  • 11/18/2025Sinovac Expands Flu Vaccine Use to Infants from 6 Months
  • 11/18/2025China and the US Intensify Battle for Biotech Leadership
  • 11/18/2025Roche's Subcutaneous PD-L1 Therapy Wins China Approval
  • 11/18/2025NMPA Issues the 98th Batch of the Reference Formulations Catalogue for...
  • 11/18/2025CDE Issues the Technical Guidelines for Clinical Trials of Multivalent...
  • 11/18/2025CDE Solicits Comments on Technical Guidelines for Common Clinical Issu...
  • 11/18/2025China Biopharma Strikes Record USD 19.9 B in Licensing Deals in Octobe...
  • 11/18/2025China's October Approvals Signal the Next Five Years of Translational ...
  • 11/14/2025Review of China's Late-Stage Global Innovative Drug Pipeline in 2025
  • 11/14/2025MNCs Face Diverging Fortunes and Strategic Reset in China
  • 11/14/2025NMPA Clears IND for GenSci's In-House Bispecific ADC GenSci140
  • 11/14/2025Adicon to Acquire Crown Bioscience in US$204M Deal
  • 11/14/2025Adagene and Third Arc Bio Sign Licensing Deal for Two Masked CD3 T-Cel...
  • 11/14/2025Recent Executive Moves
  • 11/13/2025Laekna Grants Qilu Pharma Exclusive Greater China Rights to LAE002 (Af...
  • 11/13/2025Kexing Biopharm Files for Hong Kong IPO to Advance Biologic and Target...
  • 11/13/2025InSilico Files for Hong Kong IPO to Accelerate AI-Driven Drug Discover...
  • 11/13/2025Kind Pharma Secures Over CNY 400M in Series C Financing to Advance L...
  • 11/13/2025Groovy Secures Series A Financing to Advance AI-Driven Drug Discovery ...
  • 11/13/2025GenFleet Registers First Phase 3 Trial of KRAS G12D Inhibitor GFH375 i...
  • 11/13/2025Biokin Postpones Planned Hong Kong IPO Amid Market Conditions
  • 11/13/2025Global Pharma and Biotech Leaders Announce New China Investments at CI...
  • 11/13/2025Alcon Expands China Strategy with Focus on Accessibility and Innovatio...
  • 11/13/2025WuXi AppTec Establishes European Headquarters in Munich
  • Page:5/805 Total number of articles:24122: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group